Thomas Chan
Impact in
- Toxicology top 2%
- Bioactive Compounds and Antitumor Agents
- Urology top 2%
- Periodontal Regeneration and Treatments
Papers in
-
- Biochemical and Molecular Research 7
- Cancer therapeutics and mechanisms 7
- Oncology 16
- Co-authors
- Morley C. Sutter (5 shared papers)Deborah W. Knapp (5 shared papers)Stephen B. Howell (7 shared papers)Ralph C. Richardson (3 shared papers)Robert Teclaw (3 shared papers)G. D. Bottoms (2 shared papers)Thomas Kuczek (4 shared papers)Dennis B. DeNicola (4 shared papers)
- Journals
- Cancer Research (6 papers)Cancer Chemotherapy and Pharmacology (4 papers)Molecular Cancer Therapeutics (3 papers)ACS Applied Energy Materials (3 papers)Drug Metabolism and Disposition (2 papers)
- Partner nations
- United StatesCanadaFrance
In The Last Decade
Thomas Chan
65 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 118
- Toxicology 108
- Urology 160
- Small Animals 125
- Biochemistry 108
- Physiology 55
Countries citing papers authored by Thomas Chan
This map shows the geographic impact of Thomas Chan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Chan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Chan more than expected).
Fields of papers citing papers by Thomas Chan
This network shows the impact of papers produced by Thomas Chan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Chan. The network helps show where Thomas Chan may publish in the future.
Co-authors
The 25 scholars most cited alongside Thomas Chan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 68 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1994 | 244 | |
| 2 | 1998 | 191 | |
| 3 | 2011 | 119 | |
| 4 | 1992 | 99 | |
| 5 | 1998 | 89 | |
| 6 | 1985 | 66 | |
| 7 | 1993 | 66 | |
| 8 | 1983 | 65 | |
| 9 | 1982 | 57 | |
| 10 | 1995 | 57 | |
| 11 | 2002 | 57 | |
| 12 | Mechanism of synergy between N-phosphonacetyl-L-aspartate and dipyridamole in a human ovarian carcinoma cell line. | 1985 | 54 |
| 13 | 2008 | 52 | |
| 14 | 2018 | 52 | |
| 15 | 2011 | 51 | |
| 16 | 1991 | 43 | |
| 17 | 1995 | 32 | |
| 18 | Dipyridamole enhancement of etoposide sensitivity. | 1989 | 31 |
| 19 | Synergism between dipyridamole and cisplatin in human ovarian carcinoma cells in vitro. | 1992 | 29 |
| 20 | 1993 | 27 |
About Thomas Chan
Thomas Chan is a scholar working on Molecular Biology, Oncology, Renewable Energy, Sustainability and the Environment, Organic Chemistry and Electrical and Electronic Engineering, having authored 68 papers that have together received 2.0k indexed citations. Recurring topics across this work include Biochemical and Molecular Research (7 papers), Cancer therapeutics and mechanisms (7 papers), Bioactive Compounds and Antitumor Agents (6 papers), CO2 Reduction Techniques and Catalysts (6 papers), HIV/AIDS drug development and treatment (5 papers), Electrocatalysts for Energy Conversion (5 papers), Liver physiology and pathology (4 papers) and Immunotherapy and Immune Responses (4 papers). The work is most often cited by research in Toxicology (108 citations), Urology (160 citations), Small Animals (125 citations), Biochemistry (108 citations) and Physiology (55 citations). Thomas Chan has collaborated with scholars based in United States, Canada and France. Frequent co-authors include Morley C. Sutter, Deborah W. Knapp, Stephen B. Howell, Ralph C. Richardson, Robert Teclaw, G. D. Bottoms, Thomas Kuczek, Dennis B. DeNicola, Mark A. Ashwell and William V. Giannobile. Their work appears in journals such as Cancer Research, Cancer Chemotherapy and Pharmacology, Molecular Cancer Therapeutics, ACS Applied Energy Materials and Drug Metabolism and Disposition.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.